Home > SOP Information > SOPs and Supporting Information – alphabetic listing > Q to Z > Subarachnoid Haemorrhage G015 > Rulebase for subarachnoid haemorrhage > Aspirin consumption

Aspirin consumption

Subarachnoid haemorrhage - Aspirin consumption Factor

Last reviewed for CCPS 17 December 2003.

Investigative Documents

Claimant Report - Aspirin - Subarachnoid haemorrhage [CR9231]

[1] Medical Report - Aspirin - Subarachnoid haemorrhage [MR9306]

Preliminary questions [33355]

5529 — the veteran has taken salicylic acid (aspirin) at some time. [Default true]

33338 — the veteran has established the causal connection between consuming aspirin and VEA service for the clinical onset of subarachnoid haemorrhage.

33341 — the veteran has established the causal connection between the aspirin consumption and operational service for the clinical onset of subarachnoid haemorrhage.

or

33342 — the veteran has established the causal connection between the aspirin consumption and eligible service for the clinical onset of subarachnoid haemorrhage.

Clinical onset and operational service [33341]

[2]33339

the veteran consumed at least 2100 mg of aspirin within a seven day period within the 21 days immediately before the clinical onset of the condition under consideration.

[3]33346

the veteran's consumption of at least 2100 mg of aspirin within a seven day period within the 21 days immediately before the clinical onset of the condition under consideration was materially contributed to by treatment of an illness or injury which is identifiable.

33348 — the identified illness or injury which made a material contribution to the veteran's consumption of aspirin is causally related to operational service. [4] [5]

Clinical onset and eligible service [33342]

[6]33349

the veteran consumed at least 4200 mg of aspirin within a seven day period within the 21 days immediately before the clinical onset of the condition under consideration.

[7]33346

the veteran's consumption of at least 2100 mg of aspirin within a seven day period within the 21 days immediately before the clinical onset of the condition under consideration was materially contributed to by treatment of an illness or injury which is identifiable.

[4]33353

the identified illness or injury made a material contribution to the veteran's consumption of at least 4200 mg of aspirin within a seven day period within the 21 days immediately before the clinical onset of the condition under consideration. [8]

33354 — the identified illness or injury which made a material contribution to the veteran's consumption of aspirin is causally related to eligible service. [9] [5]

Source URL (modified on 20/10/2014 - 3:25pm): https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/subarachnoid-haemorrhage-g015-i60s066/rulebase-subarachnoid-haemorrhage/aspirin-consumption

Links
[1] https://clik.dva.gov.au/ccpsclaimant-17
[2] clikpopup://CCPS/At least 2100 mg of aspirin consumed within seven days within 21 days before onset of subarachnoid haemorrhage
[3] clikpopup://CCPS/reject33339No
[4] clikpopup://CCPS/reject33346No
[5] clikpopup://CCPS/reject33348,33354No
[6] clikpopup://CCPS/At least 4200 mg of aspirin consumed within seven days within 21 days before onset of subarachnoid haemorrhage
[7] clikpopup://CCPS/reject33349No
[8] clikpopup://CCPS/reject33353No
[9] clikpopup://CCPS/reject33354No